Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Friesen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Vaccine|July 27, 2011
Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasiteJohannes Friesen, Kai Matuschewski
Antimicrobial Agents and Chemotherapy|March 30, 2011
Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistanceJohannes Friesen, Steffen Borrmann, Kai Matuschewski
Molecular and Biochemical Parasitology|December 7, 2007
Identification of novel bradyzoite-specific Toxoplasma gondii genes with domains for protein-protein interactions by suppression subtractive hybridizationJohannes Friesen, Tobias Fleige, Uwe Gross, et al.
Human Vaccines|January 27, 2011
Arrested Plasmodium liver stages as experimental anti-malaria vaccinesKai Matuschewski, Julius Clemence Hafalla, Steffen Borrmann, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2007
Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenasesAhmad Saleh, Johannes Friesen, Stefan Baumeister, et al.
Science Translational Medicine|July 16, 2010
Natural immunization against malaria: causal prophylaxis with antibioticsJohannes Friesen, Olivier Silvie, Elyzana Dewi Putrianti, et al.
Frontiers in Microbiology|August 23, 2021
Conservation of S20 as an Ineffective and Disposable IFNγ-Inducing Determinant of <i>Plasmodium</i> Sporozoites Indicates Diversion of Cellular ImmunityCalvin Hon, Johannes Friesen, Alyssa Ingmundson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 4, 2019
Detection of Enterobius vermicularis in greater Berlin, 2007-2017: seasonality and increased frequency of detectionJohannes Friesen, Clara Bergmann, Robert Neuber, et al.
Plos Pathogens|May 16, 2013
Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profilingJulius Clemence R Hafalla, Karolis Bauza, Johannes Friesen, et al.
Gut Pathogens|April 24, 2020
Prevalence and antimicrobial susceptibility of <i>Arcobacter</i> species in human stool samples derived from out- and inpatients: the prospective German <i>Arcobacter</i> prevalence study ArcopathVanessa Brückner, Ulrike Fiebiger, Ralf Ignatius, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Vaccine|July 27, 2011
Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasiteJohannes Friesen, Kai Matuschewski
Antimicrobial Agents and Chemotherapy|March 30, 2011
Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistanceJohannes Friesen, Steffen Borrmann, Kai Matuschewski
Molecular and Biochemical Parasitology|December 7, 2007
Identification of novel bradyzoite-specific Toxoplasma gondii genes with domains for protein-protein interactions by suppression subtractive hybridizationJohannes Friesen, Tobias Fleige, Uwe Gross, et al.
Human Vaccines|January 27, 2011
Arrested Plasmodium liver stages as experimental anti-malaria vaccinesKai Matuschewski, Julius Clemence Hafalla, Steffen Borrmann, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2007
Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenasesAhmad Saleh, Johannes Friesen, Stefan Baumeister, et al.
Science Translational Medicine|July 16, 2010
Natural immunization against malaria: causal prophylaxis with antibioticsJohannes Friesen, Olivier Silvie, Elyzana Dewi Putrianti, et al.
Frontiers in Microbiology|August 23, 2021
Conservation of S20 as an Ineffective and Disposable IFNγ-Inducing Determinant of <i>Plasmodium</i> Sporozoites Indicates Diversion of Cellular ImmunityCalvin Hon, Johannes Friesen, Alyssa Ingmundson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 4, 2019
Detection of Enterobius vermicularis in greater Berlin, 2007-2017: seasonality and increased frequency of detectionJohannes Friesen, Clara Bergmann, Robert Neuber, et al.
Plos Pathogens|May 16, 2013
Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profilingJulius Clemence R Hafalla, Karolis Bauza, Johannes Friesen, et al.
Gut Pathogens|April 24, 2020
Prevalence and antimicrobial susceptibility of <i>Arcobacter</i> species in human stool samples derived from out- and inpatients: the prospective German <i>Arcobacter</i> prevalence study ArcopathVanessa Brückner, Ulrike Fiebiger, Ralf Ignatius, et al.
Pageof 2